FNDA, the Schwab Fundamental U.S. Small Company ETF, has reversed last week's softness with conviction — the story this week is a clean price recovery in a fund where short sellers remain almost entirely absent.
The ETF gained 4.7% over the past week to close at $36.22, erasing the 2.3% decline noted in the prior note and then some. The one-month gain is a more modest 2%, suggesting the weekly move represents a genuine sentiment shift rather than simple mean reversion. There is no earnings calendar for an ETF, so what's driving the move is broader: renewed appetite for domestically focused small-cap value names, the same rotation dynamic that briefly lifted the fund in mid-May before macro headwinds intervened.
The lending market remains a complete non-story for short sellers. Short interest is just 0.026% of the free float — negligible by any measure — and it fell a further 14% over the week after a brief and now largely reversed spike through mid-May that briefly lifted it above 0.08% of float. Borrow availability is effectively unlimited, with around 2.8 million shares available for loan against fewer than 73,000 borrowed. The ORTEX short score holds at 26.4, a low reading that has barely moved in ten days. Cost to borrow has drifted lower this week, down roughly 11% to 2.24% — a figure that reflects the mechanics of ETF creation-redemption rather than any genuine demand for short exposure. Nothing in the lending market suggests directional conviction from short sellers.
Options positioning offers no contrarian signal either. The put/call ratio has sat at zero for five consecutive sessions, well below its already-thin 20-day average of 0.01. The 52-week high for the PCR was just 0.67, itself a modest reading for an ETF of this type. Options activity on FNDA is sparse enough that the data functions more as confirmation of disinterest than as a sentiment indicator in its own right.
The dividend history adds a minor note of context. The most recent distribution of $0.0603 per share was announced in February 2026 for a March payment. At the current price of $36.22, that translates to a modest annualised yield, consistent with a fundamentals-weighted small-cap strategy that prioritises value characteristics over income generation.
With the price back above $36 and short interest near zero, the setup for FNDA is almost entirely a macro read — what matters next is whether the rotation into small-cap domestics holds, or whether fiscal and rate concerns reassert the pressure that weighed on the fund through much of April and early May.
See the live data behind this article on ORTEX.
Open FNDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
